Immunoprecise Antibodies Ltd (IPA) — Working Capital to Net Assets Ratio
Immunoprecise Antibodies Ltd (IPA) has a Working Capital to Net Assets ratio of 41.2% as of April 2025. Working capital of $9.74 Million (current assets of $18.75 Million minus current liabilities of $9.01 Million) is measured against net assets of $23.63 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See IPA net asset quality score to measure how much of total assets are equity-financed.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Immunoprecise Antibodies Ltd Working Capital to Net Assets (1997–2025)
This chart shows how Immunoprecise Antibodies Ltd's Working Capital to Net Assets ratio has evolved across 29 annual periods from 1997 to 2025. As of April 2025, the ratio stands at 41.2%, reflecting working capital of $9.74 Million against net assets of $23.63 Million USD. Check how tangible is Immunoprecise Antibodies Ltd's equity to evaluate the tangible quality of the company's equity base.
Annual Working Capital to Net Assets for Immunoprecise Antibodies Ltd (1997–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for Immunoprecise Antibodies Ltd from 1997 to 2025, covering 29 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see how much is Immunoprecise Antibodies Ltd worth.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 41.2% | $9.74 Million | $23.63 Million | $18.75 Million | $9.01 Million | ▲ +31.3 pp |
| 2024 | 9.9% | $3.36 Million | $33.92 Million | $11.49 Million | $8.12 Million | ▼ -8.9 pp |
| 2023 | 18.8% | $10.87 Million | $57.80 Million | $16.79 Million | $5.92 Million | ▼ -18.7 pp |
| 2022 | 37.5% | $28.21 Million | $75.28 Million | $37.47 Million | $9.26 Million | ▼ -37.7 pp |
| 2021 | 75.2% | $42.79 Million | $56.92 Million | $48.86 Million | $6.07 Million | ▲ +76.7 pp |
| 2020 | -1.5% | $-230.32K | $15.09 Million | $7.70 Million | $7.93 Million | ▼ -16.3 pp |
| 2019 | 14.8% | $2.67 Million | $18.07 Million | $9.88 Million | $7.20 Million | ▲ +10.9 pp |
| 2018 | 3.9% | $498.38K | $12.70 Million | $4.78 Million | $4.28 Million | ▼ -75.2 pp |
| 2017 | 79.2% | $2.45 Million | $3.09 Million | $3.28 Million | $836.91K | ▼ -12.5 pp |
| 2016 | 91.6% | $832.24K | $908.26K | $1.22 Million | $385.52K | ▼ -9.8 pp |
| 2015 | 101.4% | $-211.49K | $-208.52K | $43.16K | $254.64K | ▼ -1.1 pp |
| 2014 | 102.5% | $-165.21K | $-161.21K | $138.29K | $303.50K | ▼ 0.0 pp |
| 2013 | 102.5% | $-221.09K | $-215.66K | $44.54K | $265.63K | ▼ -3.1 pp |
| 2012 | 105.6% | $-126.58K | $-119.89K | $86.52K | $213.10K | ▲ +10.2 pp |
| 2011 | 95.4% | $151.16K | $158.40K | $261.36K | $110.21K | ▲ +94.5 pp |
| 2010 | 0.9% | $49.39K | $5.43 Million | $147.26K | $97.87K | ▼ -7.8 pp |
| 2009 | 8.7% | $592.44K | $6.78 Million | $743.28K | $150.84K | ▼ -0.2 pp |
| 2008 | 9.0% | $459.26K | $5.12 Million | $496.72K | $37.46K | ▲ +8.1 pp |
| 2007 | 0.9% | $49.67K | $5.43 Million | $463.36K | $413.69K | ▼ -13.1 pp |
| 2006 | 14.0% | $546.25K | $3.91 Million | $684.87K | $138.62K | ▼ -45.7 pp |
| 2005 | 59.7% | $2.52 Million | $4.23 Million | $2.57 Million | $47.18K | ▲ +15.0 pp |
| 2004 | 44.6% | $622.27K | $1.39 Million | $672.19K | $49.92K | ▲ +42.8 pp |
| 2003 | 1.9% | $16.15K | $867.54K | $45.69K | $29.53K | ▲ +21.8 pp |
| 2002 | -19.9% | $-137.94K | $691.56K | $49.78K | $187.72K | ▲ +187.9 pp |
| 2001 | -207.8% | $-544.93K | $262.24K | $351.82K | $896.75K | ▼ -280.7 pp |
| 2000 | 72.9% | $288.92K | $396.53K | $299.03K | $10.11K | ▲ +43.6 pp |
| 1999 | 29.2% | $473.78K | $1.62 Million | $509.56K | $35.78K | ▼ -7.2 pp |
| 1998 | 36.4% | $1.04 Million | $2.86 Million | $1.11 Million | $66.92K | ▼ -28.4 pp |
| 1997 | 64.8% | $2.35 Million | $3.63 Million | $2.60 Million | $250.04K | — |